NCT01055756

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Azidus Brasil · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (loratadine + pseudoephedrine sulfate - Schering Plough) in patients with allergic rhinitis by quantification of the scores of clinical parameters (signs and symptoms) and laboratory (nasal flow) down through time.

Detailed description

Secondly, it will be observed safety (tolerability) clinic after the administration of the drug in patients by comparing the clinical parameters and the incidence of adverse events.

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Loratadine + Pseudoephedrine sulfate	Loratadine (5 mg) + Pseudoephedrine sulfate (120 mg)

Timeline

• Start date: 2010-01-01
• Primary completion: 2010-04-01
• Completion: 2010-06-01
• First posted: 2010-01-26
• Last updated: 2022-10-31

Locations

1 site across 1 country: Brazil